NVG and NZF deploy over 40% leverage and hold 74–75% investment-grade bonds, with notable exposure to Illinois, Texas, and California. Click here to read more.
Reinforced NVG-291's broad therapeutic potential with new data across three distinct injury models Vancouver, British Columbia--(Newsfile Corp. - August 21, 2025) - NervGen Pharma Corp. (TSXV: NGEN) ...
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...
Nuvig Therapeutics has dosed the first subject in its multi-centre Phase II INVGOR trial of recombinant human immunoglobulin G1-crystallisable fragment (IgG1-Fc) fusion protein, NVG-2089, for ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nuvig Therapeutics, Inc. (“Nuvig” or the “Company”), a privately held biotechnology company developing novel immunomodulatory therapeutics for patients with ...
The freshly released Season 1 Reloaded patch notes indicate a brand-new NVG Gulag event in Warzone. The likes of which have never been seen, the community is up for a treat as new game modes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results